Viridian Therapeutics, Inc.

Biotechnology company · Waltham, Massachusetts, United States

Viridian Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Viridian Therapeutics at a glance

Typebiotechnology company

HeadquartersWaltham, Massachusetts, United States

Earliest incorporation on record2020

SEC CIK1811466

What does Viridian Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $27 million sold (2020).

Frequently asked questions about Viridian Therapeutics

Where is Viridian Therapeutics headquartered?

Viridian Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Viridian Therapeutics do?

Viridian Therapeutics, Inc. is a biotechnology company.

When was Viridian Therapeutics founded?

The earliest incorporation on record for Viridian Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Repligen CorpWaltham, Massachusetts, United States
TScan Therapeutics, Inc.Waltham, Massachusetts, United States
La Jolla Pharmaceutical CoWaltham, Massachusetts, United States
MINERVA BIOTECHNOLOGIES CorpWaltham, Massachusetts, United States
Dianthus Therapeutics, Inc.Waltham, Massachusetts, United States
Pyramid Biosciences, Inc.Waltham, Massachusetts, United States
Mythic Therapeutics, Inc.Waltham, Massachusetts, United States
Solarea Bio, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences